Basics Apogee Therapeutics, Inc. IPO Date: July 14, 2023 Sector: Healthcare Industry: Biotech Market Cap: $5.24B Activated in VL: True Average Daily Range Avg Daily Range: $1.12 | 2.80% Avg Daily Range (30 D): $1.43 | 2.29% Avg Daily Range (90 D): $1.13 | 2.34% Institutional Daily Volume Avg Daily Volume: .44M Avg Daily Volume (30 D): .6M Avg Daily Volume (90 D): .52M Trade Size Avg Trade Size (Sh.): 54 Avg Trade Size (Sh.) (30 D): 50 Avg Trade Size (Sh.) (90 D): 48 Institutional Trades Total Inst.Trades: 1,268 Avg Inst. Trade: $2.74M Avg Inst. Trade (30 D): $2.9M Avg Inst. Trade (90 D): $3.05M Avg Inst. Trade Volume: .06M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.06M Avg Closing Trade (30 D): $5.65M Avg Closing Trade (90 D): $5.28M Avg Closing Volume: 92.27K     News Nov 10, 2025 @ 12:00 PM Apogee Therapeutics Announces Positive Interim Pha... Source: Apogee Therapeutics Oct 10, 2025 @ 8:01 PM Apogee Therapeutics, Inc. Announces Closing of Pub... Source: Apogee Therapeutics, Inc. Oct 9, 2025 @ 9:26 PM Why Apogee Therapeutics Stock Triumphed on Thursda... Source: Eric Volkman Oct 9, 2025 @ 1:52 AM Apogee Therapeutics, Inc. Announces Pricing of $30... Source: Apogee Therapeutics, Inc. Jul 7, 2025 @ 10:00 AM Apogee Therapeutics Announces Positive 16-Week Dat... Source: Apogee Therapeutics Financials   TTM Q2 2025 Q1 2025 Basic EPS $-1.11 $-1.13 $-.95 Diluted EPS $-1.11 $-1.13 $-.95 Revenue $ M $ M $ M Gross Profit $ $ $ Net Income / Loss $ -65.02M $ -66.1M $ -55.34M Operating Income / Loss $ -71.28M $ -73.17M $ -63.1M Cost of Revenue $ $ $ Net Cash Flow $ -16.57M $ 17.28M $ -34.87M PE Ratio     Splits Jan 08, 2008:   1:50